Clinical trial
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
NCT00136760 · Brown University, Other · Completed
Key facts
| NCT number | NCT00136760 |
|---|---|
| Title | Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia |
| Official title | Incentives Plus Bupropion for Smoking in Schizophrenics |
| Lead sponsor | Brown University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia and Disorders With Psychotic Features, Tobacco Use Disorder |
| Intervention type | Drug |
| Interventions | Bupropion, Contingent reinforcement plus placebo, non-contingent reinforcement plus bupropion, Non-contingent reinforcement plus placebo |
| Enrollment | 57 |
| Start date | Sep 1, 2003 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Aug 29, 2005 |
| Last update posted | Oct 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: